In vivo effects of chicken myelomonocytic growth factor: delivery via a viral vector.
We have constructed a recombinant fowlpox virus (FPV) that expresses chicken myelomonocytic growth factor (cMGF). Administration of this construct (fp/cMGF) to 1-day-old chicks resulted in a marked and sustained increase in the number of circulating blood monocytes compared with chicks infected with the parental FPV strain (fp/M3). Blood monocyte numbers were elevated within 4 days of fp/cMGF infection, reached maximal levels at day 9, and returned to normal levels by day 16. During the peak response, approximately 35% of blood leukocytes were monocytes, compared with 4 to 7% in uninfected control birds. Infection with fp/M3 also resulted in a detectable increase in monocyte numbers; however, the effect was less dramatic. Compared with fp/M3, fp/cMGF consistently induced two- to threefold higher monocyte numbers, and the period of monocytosis was longer (10 vs 5 days). No other specific changes in white blood cell populations were observed. Associated with the increase in the number of monocytes was an increase in their state of activation, as measured by the ability to produce nitric oxide (NO) and to phagocytose latex beads. Blood monocytes from birds infected with fp/cMGF produced about 6 times as much NO per cell compared with monocytes from fp/M3-infected birds. Monocytes from normal birds failed to produce detectable levels of NO. Furthermore, cMGF treatment specifically induced enhanced phagocytic activity in blood monocytes. Overall, these results indicate that viral vectors are suitable for the delivery of biologically active cytokines and that they allow an assessment of cytokine activities in vivo.
York
J J
JJ
CSIRO Division of Animal Health, Parkville, Victoria, Australia.
Strom
A D
AD
Connick
T E
TE
McWaters
P G
PG
Boyle
D B
DB
Lowenthal
J W
JW
D000818:Animals; D015214:Antigens, Differentiation, Myelomonocytic / Q000008:administration & dosage / Q000235:genetics* / Q000494:pharmacology*; D001483:Base Sequence; D002645:Chickens; D018076:DNA, Complementary / Q000378:metabolism; D005586:Fowlpox / Q000235:genetics / Q000276:immunology; D005587:Fowlpox virus / Q000235:genetics*; D005822:Genetic Vectors / Q000008:administration & dosage / Q000494:pharmacology*; D016298:Hematopoietic Cell Growth Factors / Q000008:administration & dosage / Q000235:genetics* / Q000494:pharmacology*; D008969:Molecular Sequence Data; D009000:Monocytes / Q000276:immunology; D010587:Phagocytosis; D016133:Polymerase Chain Reaction; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000494:pharmacology
D015214:Antigens, Differentiation, Myelomonocytic; D018076:DNA, Complementary; D016298:Hematopoietic Cell Growth Factors; D011994:Recombinant Proteins